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Hydroxylation of two proline residues in hypoxia inducible factor Hif-1a is a key step in the response to
hypoxia. Here, Chowdury et al. (2009) elucidate the structural basis of this process by describing a structure
for prolyl hydroxylase PHD2 bound to a peptide substrate.Non-heme iron-dependent oxygenase
enzymes are involved in a wide variety
of biochemical pathways, ranging from
natural product biosynthesis, where they
catalyze important reactions in b-lactam
and glycopeptide antibiotic biosynthesis,
to oxidative degradation pathways, where
they catalyze hydroxylation and oxidative
cleavage reactions in the breakdown
of naturally occurring and xenobiotic me-
tabolites. Over the last ten years, it has
emerged that oxygenases play a key role
in signaling pathways for oxygen sensing
in mammals. The hypoxia-inducible factor
HIF-1a, which regulates transcription of
a set of genes under hypoxic conditions,
is hydroxylated on two proline residues,
Pro-564 and Pro-402, by a set of three
2-oxoglutarate-dependent prolyl hydroxy-
lases (human PHD 1, 2, and 3), leading to
ubiquitin-mediated degradation (Schofield
and Ratcliffe, 2004). These hydroxylation
steps respond directly to oxygen levels in
cells, since oxygen is the substrate for
hydroxylation, and therefore provide the
link between oxygen concentration and
cell signaling.
The structural basis of peptide hydrox-
ylation by thePHD family has been eagerlyawaited. The close relative of this group of
enzymes is collagen prolyl hydroxylase,
catalyzing the hydroxylation of multiple
proline residues in the structural protein
collagen, which has been studied for
many years but has until recently eluded
structure determination, in the form of an
algal prolyl 4-hydroxylase enzyme (Koski
et al., 2007). The structure of human PHD
was determined in 2006, revealing that
the active site iron (II) cofactor is ligated
by a facial tridentate set of ligands
(His-313, Asp-315, His-374) and is buried
quite deeply in the active site pocket,
explaining the formationof a tight complex
with iron (II) and 2-oxoglutarate (McDo-
nough et al., 2006). The facial tridentate
His, His, Asp/Glu ligand set is foundwidely
in non-heme iron-dependent enzymes
(Koehntop et al., 2005), and allowsbinding
of a bidentate substrate or cosubstrate
(such as 2-oxoglutarate), and a sixth
co-ordination site that can be used for
dioxygen binding.
In this issue, Chowdury et al. (2009)
report the first structure of a complex
between PHD2 and its substrate peptide
CODD, revealing interactions between
the enzyme and its substrate. In compar-ison with the structure of ligand-free
PHD2,asignificantconformationalchange
of the b2b3 loop is observed. The confor-
mational change appears to be anchored
by a salt bridge between Arg-252 and
Asp-254, which can be targeted for the
development of enzyme inhibitors. The
structure also elegantly confirms recent
stereo-chemical studies (Loenarz et al.,
2009) that suggest that the conformation
of theprolyl residueof theboundsubstrate
is important for recognition and catalysis.
The bound prolyl residue (corresponding
to Pro-564 of HIF-1a) adopts a C4 endo
conformation, in which the proR hydrogen
at C-4 points directly toward the site
where the reactive iron (IV) oxo interme-
diate will form during the catalytic mecha-
nism (see Figure 1). In contrast, the
product adopts a C4 exo conformation, in
which the 4-hydroxyl group forms an unfa-
vorable steric clash with nearby active site
residues, thereby promoting product
release.
Unlike oxygenases that bind small mole-
cule substrates, these prolyl hydroxylase
enzymes are binding polypeptide sub-
strates,which bring additional demands on
the enzyme. The hydroxylation site mustFigure 1. Conformations of Prolyl Residue in the Substrate and Product of the PHD2 Catalyzed Reaction
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bound to the hydroxylase active site. This
might require some local conformational
changes in the polypeptide substrate,
necessitating energy expenditure to over-
come protein folding interactions. It there-
fore may be important that the PHD2
prolyl hydroxylase structure is flexible and
dynamic, which was also observed in the
structure of prolyl 4-hydroxylase (Koski
et al., 2007). Similar issues are faced by
protein kinase and phosphatase enzymes
that catalyze phosphorylation and dephos-
phorylation reactions on polypeptide sub-
strates. Protein tyrosine phosphatase 1B
is known to undergo a conformational
change of a surface loop upon binding of
its peptide substrate (Jia et al., 1995), and
it is known that inhibitors can bind to an
allosteric site that blocks the mobility of
this loop (Wiesmann et al., 2004). Structure
determinationof theSrcprotein kinasewith
or without bound inhibitors also showsKasA, Another Bri
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Mycobacterium tuberculosis, the ca
for centuries, has a unique cell wall
now describe the structure of KasA
The mycobacterial cell wall contains an
unusually complex, lipid-rich coat that
has been proposed to help the pathogen
survive the harsh environment of the
macrophage and is thought to provide
intrinsic resistance to common anti-
bacterial agents. The most distinctive
feature of the cell wall is the presence
of very long chain (C60-90) a-branched,
b-hydroxy fatty acids, known as mycolic
acids. In the mycobacterial cell wall, my-
colic acids exist in the form of trehalose
dimycolate (TDM or chord factor), or
they are esterified to the nonreducing
termini of the arabinogalactan-peptido-
glycan complex (Brennan and Nikaido,
1995).
914 Structure 17, July 15, 2009 ª2009 Elseevidence of conformational changes in
the protein structure (Breitenlechner et al.,
2005).
There are indications that 2-oxogluta-
rate-dependent oxygenases are involved
in a variety of biochemical and signaling
pathways in mammals and metazoans
(Loenarz and Schofield, 2008). It may
therefore prove to be the case that protein
hydroxylation is a more widespread post-
translational modification reaction than
previously thought.
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plants. Indeed, mycobacteria are unusual
in that they have both the FAS-I and FA-
S-II systems. The mycobacterial FAS-II
system can only elongate a C16-C20-acyl
chain into a mixture of mycolic acids that
range from C54 to C63. KasA belongs to
the FAS-II system and employs FAS-I
products as starter molecules to synthe-
size meromycolates, fatty acids with C50
chain lengths or longer that are intermedi-
ates in mycolic acid production, by
a condensation reaction using malonyl-
ACPM.
Another interesting aspect of the myco-
bacterial mycolic acid biosynthetic
pathway is the presence of three homolo-
gous condensing enzymes in the FAS-II
